Pharmacist-implemented intervention to surmount COVID-19 vaccination hesitancy in adults with substance use disorders.
Am J Health Syst Pharm
; 81(16): 706-712, 2024 Aug 12.
Article
em En
| MEDLINE
| ID: mdl-38557904
ABSTRACT
PURPOSE:
Substance use disorders (SUDs) increase the risk and severity of infectious diseases, including coronavirus disease 2019 (COVID-19). Adults with a co-occurring SUD and psychiatric disorder were studied to elucidate the association between SUD severity and (1) COVID-19 vaccination status, (2) receptivity to a one-session intervention with a pharmacist advocating the benefits of vaccination, and (3) acceptance of referral for vaccination following the intervention.METHODS:
COVID-19 vaccination status was recorded in 460 adults with SUD (324 males and 136 females) upon entry into inpatient treatment. A 2-parameter item response theory (IRT) model quantified SUD severity. Pharmacist-delivered intervention, modeled after the screening, brief intervention, and referral to treatment (SBIRT) protocol, was offered to unvaccinated participants.RESULTS:
Higher SUD severity was associated with a lower vaccination rate. Nicotine, opioid, and sedative use disorders were most frequently associated with unvaccinated status. SUD severity was not associated with receptivity to intervention advocating vaccination or subsequent acceptance of a referral for vaccination. The portion of the sample that received the intervention was over 7 times more likely to accept a referral for vaccination when compared to participants who rejected the intervention (20.8% vs 2.8%).CONCLUSION:
Pharmacist-administered intervention produced motivation for vaccination in a number of recipients; however, receptivity to the intervention was not related to SUD severity.Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Farmacêuticos
/
Transtornos Relacionados ao Uso de Substâncias
/
Vacinas contra COVID-19
/
COVID-19
/
Hesitação Vacinal
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Am J Health Syst Pharm
Assunto da revista:
FARMACIA
/
HOSPITAIS
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
Panamá